![Frontiers | Hyperglycemia-Induced Dysregulated Fusion Intermediates in Insulin-Secreting Cells Visualized by Super-Resolution Microscopy | Cell and Developmental Biology Frontiers | Hyperglycemia-Induced Dysregulated Fusion Intermediates in Insulin-Secreting Cells Visualized by Super-Resolution Microscopy | Cell and Developmental Biology](https://www.frontiersin.org/files/Articles/650167/fcell-09-650167-HTML-r1/image_m/fcell-09-650167-g001.jpg)
Frontiers | Hyperglycemia-Induced Dysregulated Fusion Intermediates in Insulin-Secreting Cells Visualized by Super-Resolution Microscopy | Cell and Developmental Biology
![Genotype-phenotype correlation analysis and therapeutic development using a patient stem cell-derived disease model of Wolfram syndrome | bioRxiv Genotype-phenotype correlation analysis and therapeutic development using a patient stem cell-derived disease model of Wolfram syndrome | bioRxiv](https://www.biorxiv.org/content/biorxiv/early/2021/11/08/2021.11.07.467657/F4.large.jpg)
Genotype-phenotype correlation analysis and therapeutic development using a patient stem cell-derived disease model of Wolfram syndrome | bioRxiv
![Circular RNA circ‑CCT3 promotes hepatocellular carcinoma progression by regulating the miR‑1287‑5p/TEAD1/PTCH1/LOX axis Circular RNA circ‑CCT3 promotes hepatocellular carcinoma progression by regulating the miR‑1287‑5p/TEAD1/PTCH1/LOX axis](https://www.spandidos-publications.com/article_images/mmr/23/5/mmr-23-05-12014-g01.jpg)
Circular RNA circ‑CCT3 promotes hepatocellular carcinoma progression by regulating the miR‑1287‑5p/TEAD1/PTCH1/LOX axis
![TRPA1–FGFR2 binding event is a regulatory oncogenic driver modulated by miRNA-142-3p | Nature Communications TRPA1–FGFR2 binding event is a regulatory oncogenic driver modulated by miRNA-142-3p | Nature Communications](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41467-017-00983-w/MediaObjects/41467_2017_983_Fig1_HTML.jpg)
TRPA1–FGFR2 binding event is a regulatory oncogenic driver modulated by miRNA-142-3p | Nature Communications
![CircMEG3 inhibits telomerase activity by reducing Cbf5 in human liver cancer stem cells: Molecular Therapy - Nucleic Acids CircMEG3 inhibits telomerase activity by reducing Cbf5 in human liver cancer stem cells: Molecular Therapy - Nucleic Acids](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/6aba726d-1e0b-4316-9ce6-c25b8fecbafb/gr7_lrg.jpg)
CircMEG3 inhibits telomerase activity by reducing Cbf5 in human liver cancer stem cells: Molecular Therapy - Nucleic Acids
![MICU1 controls cristae junction and spatially anchors mitochondrial Ca2+ uniporter complex | Nature Communications MICU1 controls cristae junction and spatially anchors mitochondrial Ca2+ uniporter complex | Nature Communications](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41467-019-11692-x/MediaObjects/41467_2019_11692_Fig1_HTML.png)
MICU1 controls cristae junction and spatially anchors mitochondrial Ca2+ uniporter complex | Nature Communications
![Frontiers | Nucleic Acid-Based Treatments Against COVID-19: Potential Efficacy of Aptamers and siRNAs | Microbiology Frontiers | Nucleic Acid-Based Treatments Against COVID-19: Potential Efficacy of Aptamers and siRNAs | Microbiology](https://www.frontiersin.org/files/Articles/758948/fmicb-12-758948-HTML-r1/image_m/fmicb-12-758948-g001.jpg)